Lucijanić, M., Sabljić, A., Vlasac Glasnović, J., Sorić, E., Jonjić, Ž. i Kušec, R. (2023). Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab. Annals of Hematology, 103. (3), 1015-1016. doi: 10.1007/s00277-023-05565-z
Lucijanić, Marko, et al. "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab." Annals of Hematology, vol. 103, br. 3, 2023, str. 1015-1016. https://doi.org/10.1007/s00277-023-05565-z
Lucijanić, Marko, Anica Sabljić, Josipa Vlasac Glasnović, Ena Sorić, Željko Jonjić i Rajko Kušec. "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab." Annals of Hematology 103, br. 3 (2023): 1015-1016. https://doi.org/10.1007/s00277-023-05565-z
Lucijanić, M., et al. (2023) 'Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab', Annals of Hematology, 103(3), str. 1015-1016. doi: 10.1007/s00277-023-05565-z
Lucijanić M, Sabljić A, Vlasac Glasnović J, Sorić E, Jonjić Ž, Kušec R. Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab. Annals of Hematology [Internet]. 25.11.2023. [pristupljeno 19.08.2024.];103(3):1015-1016. doi: 10.1007/s00277-023-05565-z
M. Lucijanić, A. Sabljić, J. Vlasac Glasnović, E. Sorić, Ž. Jonjić i R. Kušec, "Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab", Annals of Hematology, vol. 103, br. 3, str. 1015-1016, Studeni 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:633355. [Citirano: 19.08.2024.]